|
Volumn 34, Issue 6, 2002, Pages 2482-2484
|
Pre- and posttransplant immunologic monitoring: Why, when, and how?
a
RIZK HOSPITAL
(Lebanon)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
CYCLOSPORIN A;
CYTOKINE;
INTERFERON;
INTERLEUKIN 10;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 4;
INTERLEUKIN 6;
RANTES;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR ALPHA;
ANTIGEN PRESENTATION;
ANTIGEN RECOGNITION;
CELLULAR IMMUNITY;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
CYTOMEGALOVIRUS INFECTION;
DNA POLYMORPHISM;
GENOTYPE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY;
HUMAN;
IMMUNE RESPONSE;
IMMUNOTOXICITY;
INFECTION;
LYMPHOCYTE PROLIFERATION;
MAJOR HISTOCOMPATIBILITY COMPLEX;
ORGAN DONOR;
ORGAN TRANSPLANTATION;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RECIPIENT;
SURVIVAL;
T LYMPHOCYTE;
GRAFT SURVIVAL;
HUMANS;
MONITORING, IMMUNOLOGIC;
POSTOPERATIVE PERIOD;
PREOPERATIVE CARE;
TRANSPLANTATION IMMUNOLOGY;
|
EID: 0036755316
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03184-6 Document Type: Conference Paper |
Times cited : (4)
|
References (32)
|